Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

RSS Feed

Home
/
Brands
/
Boothwyn Pharmacy LLC

Boothwyn Pharmacy LLC Recalls

All product recalls associated with Boothwyn Pharmacy LLC.

Get alerts for this brand

Recall Summary

Total Recalls

Past Year

Class I (Serious)

Most Recent

Jul 2025

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–4 of 4 recalls

Semaglutide Injection 4mL (Boothwyn Pharmacy) – Subpotent Drug (2025)

Subpotent Drug

Class IIModerate

FDAJul 9, 2025Nationwide• Boothwyn Pharmacy LLC

Semaglutide Injection (Boothwyn Pharmacy) – Subpotent Drug (2025)

Subpotent Drug

Class IIModerate

FDAJul 9, 2025Nationwide• Boothwyn Pharmacy LLC

Semaglutide Injection (Boothwyn Pharmacy) – Potency Issue (2025)

Subpotent Drug

Class IIModerate

FDA

Jul 9, 2025

Nationwide

• Boothwyn Pharmacy LLC

Fluorescein 2% Ophth (Boothwyn Pharmacy) – Subpotent Drug (2025)

Subpotent Drug

Class IIILow

FDAJul 9, 2025Nationwide• Boothwyn Pharmacy LLC